Teva Fined Around $500 Million Over MS Drug Competition Concerns
Read more at The Wall Street Journal
Topics
-
EU Commission fines Teva $500M for trying to stop rival's multiple sclerosis drug
World - ABC News - October 31 -
EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
Health - ABC News - October 31 -
EU fines world’s largest generic drugmaker Teva for hindering competition
Business - Financial Times - October 31 -
Intel wins lengthy EU legal battle over £880m competition fine
World - The Guardian - October 24 -
Delta Sues Crowdstrike Over Outage That Cost $500 Million
Business - Inc. - October 27 -
Amgen says no concerns around weight loss drug’s bone density data after stock falls
Business - CNBC - November 13 -
LinkedIn fined $335 million over digital advertising in Europe
Business - MarketWatch - October 24 -
Meta Fined $843 Million by EU Over Marketplace Ads Platform
Tech - The Wall Street Journal - November 14
More from The Wall Street Journal
-
7-Eleven, the Slurpee and a $47 Billion Takeover Battle
Business - The Wall Street Journal - 8 hours ago -
He Bought a Sub Shop as a Teen. Now He's Selling Jersey Mike's for $8 Billion.
Business - The Wall Street Journal - 8 hours ago -
Auto & Transport Roundup: Market Talk
Business - The Wall Street Journal - 12 hours ago -
Energy & Utilities Roundup: Market Talk
Business - The Wall Street Journal - 12 hours ago -
Financial Services Roundup: Market Talk
Business - The Wall Street Journal - 12 hours ago
